Telvilite 80 H combines Telmisartan (80 mg), an angiotensin II receptor blocker (ARB), with Hydrochlorothiazide (12.5 mg), a thiazide diuretic. This once-daily medication is designed to lower high blood pressure (hypertension) by relaxing blood vessels and promoting the elimination of excess sodium and water through urine.
It is widely prescribed for:
Patients with moderate to severe hypertension
Individuals whose blood pressure is not controlled with monotherapy
Those at risk of cardiovascular events, including heart attack or stroke
Key Features:
Dual-mechanism action for enhanced blood pressure control
Long-lasting 24-hour efficacy with once-daily dosing
Helps reduce risks of stroke, kidney failure, and heart disease
Well-tolerated with a proven safety profile
Suitable for long-term management under doctor supervision
Telvilite 80 H is especially useful in patients with coexisting conditions such as diabetes or obesity, where precise blood pressure control is essential. Regular monitoring of electrolytes and kidney function is recommended during treatment.